Showing results (1-10 of 1,570) with videos related to
Sort By:
Pageof 157
Methods in Molecular Medicine|March 5, 2011
Adjuvants for plasmid DNA vaccinesJ Norman, J Hartikka, P Strauch, et al.Human Gene Therapy|December 16, 1998
Enhancer and promoter chimeras in plasmids designed for intramuscular injection: a comparative in vivo and in vitro studyK M Barnhart, J Hartikka, M Manthorpe, et al.Gene Therapy|April 1, 1996
Novel, high expressing and antibiotic-controlled plasmid vectors designed for use in gene therapyX Liang, J Hartikka, L Sukhu, et al.Methods in Molecular Medicine|March 5, 2011
Development and characterization of lyophilized DNA vaccine formulationsN L Shen, J Hartikka, N A Horn, et al.Gene Therapy|July 1, 1997
Spatial-temporal patterns of gene expression in mouse skeletal muscle after injection of lacZ plasmid DNAS G Doh, H L Vahlsing, J Hartikka, et al.Vaccine|March 3, 2001
Vaxfectin enhances the humoral immune response to plasmid DNA-encoded antigensJ Hartikka, V Bozoukova, M Ferrari, et al.Human Gene Therapy|August 1, 1993
Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in miceM Manthorpe, F Cornefert-Jensen, J Hartikka, et al.Human Gene Therapy|June 20, 1996
An improved plasmid DNA expression vector for direct injection into skeletal muscleJ Hartikka, M Sawdey, F Cornefert-Jensen, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 1, 1988
Development of septal cholinergic neurons in culture: plating density and glial cells modulate effects of NGF on survival, fiber growth, and expression of transmitter-specific enzymesJ Hartikka, F HeftiJournal of Neuroscience Research|October 1, 1988
Comparison of nerve growth factor's effects on development of septum, striatum, and nucleus basalis cholinergic neurons in vitroJ Hartikka, F HeftiPageof 157